Mylan
Myhep
MYHEP contains Drug / Molecule called “SOFOSBUVIR”. It is the first-in-class NS5B polymerase inhibitor for hepatitis C treatment and represents a paradigm shift in the existing hepatitis C management. It is highly potent, with good safety profile and the limited drug-drug interactions of sofosbuvir makes it a breakthrough drug in hepatitis C treatment.
Indication
Myhep is used for treatment of Hepatitis C.
Note
Precaution
- Myhep (sofobuvir) is a prescription drug and should be used under proper medical guidance and advice.
- Extreme caution must be taken to avoid pregnancy.
Updated On Oct 17, 2019 by Admin
Strength
400 mg
Packing
1 x 28 Tablets (Bottle)
Storage
Store at room temperature 25°C.
Was this page helpful?
Related Products
NATCO PHARMA LIMITED (INDIA)
Velpanat
NATCO PHARMA LIMITED (INDIA)
Sofosbuvir & velpatasvir-velpanat
Hetero Healthcare Ltd. (INDIA)
Ledifos
Mylan
Mydacla
Most Viewed Products
CIPLA LTD. (INDIA)
Abiraterone acetate-xbira
NATCO PHARMA LIMITED (INDIA)
Bendamustine-bendit
CIPLA LTD. (INDIA)
Bicalutamide-cassotide
NATCO PHARMA LIMITED (INDIA)
Bortezomib-bortenat
NATCO PHARMA LIMITED (INDIA)
Erlonat
Biocon Limited
Everolimus-evertor
NATCO PHARMA LIMITED (INDIA)
Exemestane-xtane
NATCO PHARMA LIMITED (INDIA)
Geftinat
NATCO PHARMA LIMITED (INDIA)
Glatiramer acetate-glatimer
NATCO PHARMA LIMITED (INDIA)
Ledipasvir & sofosbuvir-hepcinat lp
NATCO PHARMA LIMITED (INDIA)
Lenalidomide-lenalid
NATCO PHARMA LIMITED (INDIA)
Pomalidomide-pomalid
NATCO PHARMA LIMITED (INDIA)
Sofosbuvir & velpatasvir-velpanat
NATCO PHARMA LIMITED (INDIA)
Sorafenib-sorafenat
CIPLA LTD. (INDIA)